OOIR: Observatory of International Research

Papers

(The H4-Index of Future Medicinal Chemistry is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Biological and computational evaluation of novel benzofuranyl derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors	57
Targeting Tuberculosis – An Interview With Robert Abramovitch	51
Identification of Sulfonamide-Based Butyrylcholinesterase Inhibitors Using Machine Learning	46
In vivo evaluation of novel synthetic pyrazolones as CDK9 inhibitors with enhanced pharmacokinetic properties	45
The Connection Between PARP14 and SARS-CoV-2	45
Therapeutic N -Heterocyclic Carbenes: An Interview With Alejandro Bugarin	37
Combining EGFR Inhibitors With SHP2 Or LSD1 Inhibitors to Overcome Multidrug Resistance in Cancer	37
Citrate Transporter Inhibitors: Possible New Anticancer Agents	37
A Review of Current and Promising Nontuberculous Mycobacteria Antibiotics	37
PPARγ Transcription Effect on Naturally Occurring O -Prenyl Cinnamaldehydes and Cinnamyl Alcohol Derivatives	33
Sulfonamide-salicylaldehyde Imines Active Against methicillin- and trimethoprim/sulfonamide-resistant Staphylococci	32
Investigations of New N ¹ -Substituted Pyrazoles as Anti-Inflammatory and Analgesic Agents having COX Inhibitory Act	31
Selection of SARS-CoV-2 Main Protease Inhibitor Using Structure-Based Virtual Screening	29
Design of SARS-CoV-2 Mpro, PLpro Dual-Target Inhibitors Based on Deep Reinforcement Learning and Virtual Screening	28
Super-Conserved Receptors Expressed in the Brain: Biology and Medicinal Chemistry Efforts	27
Design and synthesis of new nicotinamides as immunomodulatory VEGFR-2 inhibitors and apoptosis inducers	27
Development of 5-hydroxybenzothiophene derivatives as multi-kinase inhibitors with potential anti-cancer activity	26
Novel Set of Highly Substituted Bis-Pyridines: Synthesis, Molecular Docking and Drug-Resistant Antibacterial Profile	26
Combining Structure-Based and 3D QSAR Pharmacophore Models to Discover Diverse Ligands Against EGFR in Oral Cancer	26
Advances in AR-Targeting Chimeras: A Case Study of proteolysis-targeting Chimeras From Bench to Bedside	24
New pyrrolopyridine-based Thiazolotriazoles As Diabetics Inhibitors: Enzymatic Kinetics and In Silico Study	22
Basic nitrogen (BaN): a ‘privileged element’ in medicinal chemistry	21
A New Class of 5-HT _1A Receptor Antagonists With Procognitive and Antidepressant Properties	21